There had been warning signs about the Mylan Morgantown plant’s ultimate fate for years, even before the speciality and generic drug manufacturer merged with Pfizer-owned Upjohn to create a new company called Viatris. That merger was finalized in November 2020.
By
July 27, 2021 - 11:17 pm
MORGANTOWN, W.Va. With the closure process of the Viatris facility in Morgantown slated to begin Saturday, a leader with West Virginia University’s Bureau of Business and Economic Research says the planned action shows the importance of economic diversity.
Viatris, a company formed following the merger of Mylan Pharmaceuticals and Pfizer subsidiary Upjohn, will close the plant as part of an international business plan. Around 1,400 workers at the Morgantown facility will lose their jobs as a result of the action.
John Deskins (File)
John Deskins, the director of the Bureau of Business and Economic Research, said West Virginia has struggled with low labor participation rates and an image issue.
Joe Manchin Is Ghosting the West Virginia Union Workers Whose Jobs His Daughter Helped Outsource vanityfair.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vanityfair.com Daily Mail and Mail on Sunday newspapers.